Stock Analysis
- United States
- /
- Pharma
- /
- NasdaqGM:PAHC
Phibro Animal Health Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Phibro Animal Health (NASDAQ:PAHC) Third Quarter 2024 Results
Key Financial Results
- Revenue: US$263.2m (up 7.1% from 3Q 2023).
- Net income: US$8.40m (down 16% from 3Q 2023).
- Profit margin: 3.2% (down from 4.1% in 3Q 2023). The decrease in margin was driven by higher expenses.
- EPS: US$0.21 (down from US$0.25 in 3Q 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Phibro Animal Health Revenues Beat Expectations, EPS Falls Short
Revenue exceeded analyst estimates by 3.8%. Earnings per share (EPS) missed analyst estimates by 13%.
Looking ahead, revenue is forecast to grow 3.0% p.a. on average during the next 3 years, compared to a 9.4% growth forecast for the Pharmaceuticals industry in the US.
Performance of the American Pharmaceuticals industry.
The company's shares are up 5.6% from a week ago.
Risk Analysis
Be aware that Phibro Animal Health is showing 4 warning signs in our investment analysis and 1 of those can't be ignored...
Valuation is complex, but we're helping make it simple.
Find out whether Phibro Animal Health is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.
View the Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NasdaqGM:PAHC
Phibro Animal Health
Operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally.
Average dividend payer with moderate growth potential.